Open Access<p>Identifying Risk Factors for Regional Recurrence in Early-Stage Breast Cancer with pT1-2 and Negative Sentinel Lymph Node Biopsy</p>
Author(s) -
Kai-Yun You,
Zhuo-Fei Bi,
Lin Ding,
Yujia Ma,
Yimin Liu,
Herui Yao
Publication year - 2020
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s264267
Subject(s) - medicine , breast cancer , stage (stratigraphy) , oncology , proportional hazards model , sentinel lymph node , adjuvant therapy , sentinel node , biopsy , cancer , paleontology , biology
Due to the low rate of regional recurrence (RR) in early-stage breast cancer with pT1-2 and negative sentinel lymph node biopsy (SLNB), no regional therapy is suggested for them. However, whether there is a subset of patients who were with high risk of regional failure and may benefit from regional treatment is still unknown. The current study was designed to identify the patients with high risk of RR, thereby providing clues for enhanced regional therapy.